The mutation of PIK3R1 has been found in colorectal, breast, and ovarian cancer (Philp et al., 2001), and is also a potential therapeutic target in glioblastoma multiforme, as it regulates tumor cell growth and motility (Weber et al., 2011). Here, PIK3R1 is linked to ovarian carcinoma.